Please select how you are visiting today
Your selection will be remembered. You can change it anytime from the footer.
New product announcements, formulation changes, and availability updates.
Medivant Healthcare is proud to announce the launch of Andrela™ the first 503B cGMP compounded microdose testosterone cypionate in prefilled syringes. Testosterone therapy is not one-size-fits-all. Individualized dosing at lower therapeutic levels demands a delivery format capable of matching clinical intent exactly — and until now, that format simply didn't exist.
Medivant Healthcare is proud to announce the launch of Andrenyx™ (compounded testosterone cypionate) a single-dose prefilled syringe engineered for precision, sterility, and real-world clinical usability.
Medivant Healthcare announces its partnership with Angels for Change and the upcoming launch of Lorazepam injectable vials to help address critical drug shortages.
Medivant Healthcare announces the launch of repackaged Bevacizumab (Avastin) for ophthalmic use, offering precise dosing and consistent quality through automated prefilled syringe technology.
Medivant Healthcare announces the launch of Bupivacaine with Epinephrine 10 mL vial, a preservative-free formulation designed for reliable and precise anesthesia applications.
Medivant Healthcare announces the launch of Lidocaine 1% with Epinephrine 10 mL single-dose vials to help address nationwide shortages.
Have questions? We have answers.
